Effects of β-blockers on hemorheological parameters in experimental arterial hypertension
References
- Kreutz R, Brunström M, Burnier M, et al. 2024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension. Eur J Intern Med. 2024;126:1-15. DOI:10.1016/j.ejim.2024.05.033
- Pinho D, Carvalho V, Gonçalves IM, Teixeira S, Lima R. Visualization and measurements of blood cells flowing in microfluidic systems and blood rheology: a personalized medicine perspective. J Pers Med. 2020;10(4):249. DOI:10.3390/jpm10040249
- Mchedlishvili G. Hemorheological changes in microcirculation: mechanisms and measurement techniques. Indian J Exp Biol. 2007;45(1):32-40.
- Franco C, Sciatti E, Favero G, et al. Essential hypertension and oxidative stress. Int J Mol Sci. 2022;23:14489. DOI:10.3390/ijms232214489
- Chien S. Blood rheology in myocardial infarction and hypertension. Biorheology. 1986;23(6):633-653. DOI:10.3233/BIR-1986-23614
- Zannad F, Stoltz JF. Blood rheology in arterial hypertension. J Hypertens Suppl. 1992;10(5):S69-S78. DOI:10.1097/00004872-199207005-00010
- Pirrelli A. Arterial hypertension and hemorheology: what is the relationship? Clin Hemorheol Microcirc. 1999;21(3-4):157-160.
- Bor-Küçükatay M, Yalçin O, Gökalp O, et al. RBC rheological alterations in NO-deficient hypertension. Clin Hemorheol Microcirc. 2000;22(4):267-275.
- Kakabadze K, Megreladze I, Khvichia N, et al. Role of nitric oxide in experimental hypertension. Cardiol Res. 2021;12(1):16-24. DOI:10.14740/cr1172
- Sander M, Hansen PG, Victor RG. Sympathetically mediated hypertension caused by chronic inhibition of nitric oxide. Hypertension. 1995;26(4):691-695. DOI:10.1161/01.HYP.26.4.691
- Scrogin KE, Hatton DC, Chi Y, Luft FC. Chronic nitric oxide inhibition with L-NAME: effects on autonomic control of the cardiovascular system. Am J Physiol. 1998;274(2):R367-R374. DOI:10.1152/ajpregu.1998.274.2.R367
- Zanzinger J. Role of nitric oxide in the neural control of cardiovascular function. Cardiovasc Res. 1999;43(3):639-649. DOI:10.1016/S0008-6363(99)00085-1
- Silva IVG, de Figueiredo RC, Rios DRA. Effects of antihypertensive drugs on endothelial function. Int J Mol Sci. 2019;20(14):3458. DOI:10.3390/ijms20143458
- Kadi A, Moby V, de Isla N, et al. Nebivolol-induced NO production in endothelial cells. Biomed Mater Eng. 2008;18(4-5):279-286. DOI:10.3233/BME-2008-0543
- Wiysonge CS, Bradley HA, Volmink J, et al. Beta-blockers for hypertension. Cochrane Database Syst Rev. 2017;1:CD002003. DOI:10.1002/14651858.CD002003.pub5
- Mayer B, Holmer SR, Hengstenberg C, Lieb W, Pfeifer M, Schunkert H. Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels. Int J Cardiol. 2005;103(2):182-186. DOI:10.1016/j.ijcard.2004.08.053
- Ulleryd MA, Bernberg E, Yang LJ, Bergström GM, Johansson ME. Metoprolol reduces proinflammatory cytokines and atherosclerosis in ApoE-/- mice. Biomed Res Int. 2014;2014:548783. DOI:10.1155/2014/548783
- Hanif N, Zamir A, Imran I, et al. Clinical pharmacokinetics of nebivolol: a systematic review. Drug Metab Rev. 2023;55(4):428-440. DOI:10.1080/03602532.2023.2271195
- Frishman WH. Beta-adrenergic blockers. Circulation. 2003;107(18):e117-e119. DOI:10.1161/01.CIR.0000070983.15903.A2
- Baskurt OK, Meiselman HJ. Blood rheology and hemodynamics. Semin Thromb Hemost. 2003;29(5):435-450. DOI:10.1055/s-2003-44551
- Baskurt OK, Hardeman MR, Rampling MW, Meiselman HJ. Handbook of Hemorheology and Hemodynamics. Amsterdam: IOS Press; 2009.
- Miranda KM, Espey MG, Wink DA. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide. 2001;5(1):62-71. DOI:10.1006/niox.2000.0319
- Chrzczanowicz J, Gawron A, Zwolinska A, de Graft-Johnson J, Krajewski W, Krol M, et al. Simple method for determining human serum 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity-possible application in clinical studies on dietary antioxidants. Clin Chem Lab Med. 2008;46(3):342-349. DOI:10.1515/CCLM.2008.062
- Feuerstein GZ, Ruffolo RR Jr. Carvedilol, a novel antihypertensive agent with antioxidant activity. Eur Heart J. 1995;16(Suppl F):38-42. DOI:10.1093/eurheartj/16.suppl_F.38
Language: English
Page range: 221 - 230
Submitted on: May 5, 2026
Accepted on: Jun 22, 2026
Published on: Jul 11, 2026
Published by: Romanian Association of Laboratory Medicine
In partnership with: Paradigm Publishing Services
Related subjects:
© 2026 Nana Kajaia, Maia Mantskava, Luiza Gabunia, George Ormotsadze, Lela Chkitauri, Elene Gogichaishvili, Sophio Kalmakhelidze, Tamar V Sanikidze, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution 4.0 License.